Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy, Radiotherapy, and AZT for AIDS-Related Primary CNS Lymphoma
NCT00000723Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, zidovudine in primary central nervous system lymphoma (PCNSL), human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: terminated.
02
Drugs
methotrexatezidovudine
03
Conditions
primary central nervous system lymphoma (PCNSL)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000723.